DAWN - Day One Biopharmaceuticals, Inc.

QQQ $ 475.24 $ 0.61 (0.13 %)

DIA $ 406.80 $ 0.86 (0.21 %)

SPY $ 554.24 $ 1.24 (0.22 %)

TLT $ 97.41 $ 0.34 (0.35 %)

GLD $ 231.90 $ 5.08 (2.24 %)

Previous Close

$ 13.92

Open

Bid

$ 13.91 x 100

Ask

$ 13.94 x 100

Day's Range

-- - --

52 Week Range

$ 9.67 - $ 18.07

Volume

632,815

Average Volume

Market Cap

1.21B

Beta (5Y Monthly)

$ -0.25

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-02-2024	06-30-2024	10-Q
2	05-06-2024	03-31-2024	10-Q
3	02-26-2024	12-31-2023	10-K
4	11-06-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-01-2023	03-31-2023	10-Q
7	03-06-2023	12-31-2022	10-K
8	11-07-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-07-2022	12-31-2021	10-K
12	11-08-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JP Morgan Maintains Overweight on Day One ...
08/06/2024 16:16:55

JP Morgan analyst Anupam Rama maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and lowers the price targe...

meta-to-rally-around-35-here-are-10-top-analyst-forecasts-for-thursday

Meta To Rally Around 35%? Here Are 10 Top ...
08/01/2024 12:17:30

Day One Biopharmaceuticals shares are trad...
08/01/2024 11:39:59

HC Wainwright & Co. Reiterates Buy on Day ...
08/01/2024 10:32:55

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

B of A Securities Upgrades Day One Biophar...
08/01/2024 10:09:51

B of A Securities analyst Alec Stranahan upgrades Day One Biopharmaceutical (NASDAQ:DAWN) from Underperform to Buy and raise...

Needham Maintains Buy on Day One Biopharma...
07/31/2024 09:30:42

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $33 ...

Needham Reiterates Buy on Day One Biopharm...
07/30/2024 15:38:06

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $33 price target.

Day One Biopharmaceutical Q2 2024 GAAP EPS...
07/30/2024 11:39:39

Day One Biopharmaceuticals Announced An Ov...
07/30/2024 11:17:43

The private placement will be for 10,551,718 shares of common stock at a price of $14.50 per share. In lieu of shares of common...

HC Wainwright & Co. Reiterates Buy on Day ...
07/26/2024 11:52:23

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

why-indivior-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Why Indivior Shares Are Trading Higher; He...
07/25/2024 10:36:30

Ipsen And Day One Earlier Announced Exclus...
07/25/2024 10:10:04

Ipsen ((Euronext: IPN, OTC:IPSEY) and Day One Biopharmaceuticals (NASDAQ:DAWN) (Day One), announced today a new global partners...

Ipsen And Day One Enter Ex-U.S. Licensing ...
07/25/2024 05:54:41

Ipsen secures ex-U.S. regulatory and commercial rights to tovorafenib for most common childhood brain tumor, pediatric low-gr...

Piper Sandler Maintains Overweight on Day ...
07/08/2024 13:09:00

Piper Sandler analyst Joseph Catanzaro maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and maintains $40...

HC Wainwright & Co. Reiterates Buy on Day ...
06/20/2024 10:13:00

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

Needham Reiterates Buy on Day One Biopharm...
06/19/2024 09:37:14

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $33 price target.

Day One Biopharmaceuticals Enters Exclusiv...
06/18/2024 12:34:04

Day One To Sell Priority Review Voucher Fo...
05/30/2024 12:32:47

As part of the transaction, $8.1 million of the total consideration received from the sale of the PRV will be paid to Viracta T...

HC Wainwright & Co. Maintains Buy on Day O...
05/07/2024 10:53:34

HC Wainwright & Co. analyst Andres Maldonado maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the...

Needham Reiterates Buy on Day One Biopharm...
05/07/2024 09:56:59

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $33 price target.